Neurologists’ group issues guidance to families on controversial Alzheimer’s drug
Breakthrough in fight on tick-borne CCHF virus is latest use of new strategy against diseases
18 November 2021Study finds inequitable access to COVID-19 vaccines among countries that hosted trials
18 November 2021Neurologists’ group issues guidance to families on controversial Alzheimer’s drug
Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines.
